**Background**
Monoamine oxidase A (MAO-A) is a mitochondrial enzyme responsible for the oxidative deamination of neurotransmitters such as serotonin, norepinephrine, and dopamine. Dysregulation of MAO-A activity is closely linked to various neurological disorders, particularly depression, making it a primary target for the development of antidepressant therapies. Beyond the central nervous system, recent evidence suggests that MAO-A activity is also required for the clonal tumorsphere formation of certain human breast tumor cells, indicating its potential role in oncology. Understanding the Tetrindole biological activity provides critical insights into how selective inhibition of this enzyme can modulate both mood and tumor progression. In this context, we will introduce a selective MAO-A inhibitor – Tetrindole.
**Definition**
Tetrindole (Tetrindole mesylate) is a selective inhibitor of monoamine oxidase A (MAO-A) with a Ki value of 0.4 μM for rat brain mitochondrial MAO-A and a Ki of 110 μM for MAO-B.
**In Vitro and In Vivo Studies**
According to the Tetrindole technical information, this compound exhibits potent and selective inhibitory effects. In vitro studies demonstrated that Tetrindole mesylate possesses significant activity against human breast cancer cells; specifically, it showed IC50 values ranging from 0.51 to 1.37 μM across six human breast tumor cell lines, including MCF-7, HCC1954, T47D, MDA-MB-157, ZR75-1, and BT474. These findings suggest that Tetrindole Cancer research may expand into the inhibition of tumor sphere formation. Regarding Tetrindole in vivo activity, a single oral dose of 25 mg/kg administered to male albino rats (weighing 180-200 g) resulted in an 80% inhibition of MAO-A in both the brain and liver mitochondria within 0.5 to 1 hour. The recovery of enzyme activity became evident after 24 hours. In conclusion, Tetrindole is a selective MAO-A inhibitor with demonstrated antidepressant activity and potential antitumor effects in breast cancer cell lines.
Keywords
Tetrindole, 170964-68-8, Monoamine Oxidase, MAO, MAO A, mitochondrial, MAO B, antidepressant, Inhibitor, inhibitor, inhibit
References
[1] A E Medvedev, et al. Monoamine oxidase inhibition by novel antidepressant tetrindole. Biochem Pharmacol. 1994 Jan 20;47(2):303-8.
[2] William D Gwynne, et al. Monoamine oxidase-A activity is required for clonal tumorsphere formation by human breast tumor cells. Cell Mol Biol Lett. 2019 Nov 12;24:59.